Breaking News Instant updates and real-time market news.

INCY

Incyte

$123.11

-1.43 (-1.15%)

12:46
04/21/17
04/21
12:46
04/21/17
12:46

Incyte call volume above normal and directionally bullish

Bullish option flow detected in Incyte with 1,036 calls trading, 1.7x expected, and implied vol increasing almost 2 points to 45.76%. Jan-19 175 calls and Jun-17 100 calls are the most active options, with total volume in those strikes near 580 contracts. The Put/Call Ratio is 0.48. Earnings are expected on May 4th.

  • 04

    May

INCY Incyte
$123.11

-1.43 (-1.15%)

04/17/17
LEER
04/17/17
NO CHANGE
LEER
Outperform
Leerink sees attractive buying opportunity in Eli Lilly ahead of Q1 results
While noting that Eli Lilly's (LLY) stock is under pressure following the news that baricitinib did not receive FDA approval with the Agency expressing concerns over dosing and safety, Leerink sees an "attractive buying opportunity" ahead of Q1 results given "strong trends" in the company's new product launches, particularly for high-margin Trulicity and Taltz. Further, the firm says that while baricitinib could face a 12-18 month delay in the U.S., it is already approved in EU and is not the biggest valuation driver due to the 18% royalty it pays to partner Incyte (INCY). Leerink has Outperform ratings on Eli Lilly and Incyte's shares.
04/17/17
04/17/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Eli Lilly (LLY) was downgraded to Equal Weight from Overweight at Morgan Stanley and to Underperform from Market Perform at BMO Capital. 2. Incyte (INCY) downgraded to Neutral from Overweight at Piper Jaffray with analyst Joshua Schimmer citing the complete response letter from the FDA for baricitinib, indicating a need to determine appropriate doses. This setback could take years and lead to approval of only the lower dose, leaving potentially little differentiation from Pfizer's (PFE) rheumatoid arthritis treatment Xeljanz," Schimmer tells investors in a research note. The analyst prefers to wait for a "cleaner entry point" into the shares. 3. KKR (KKR) downgraded to Neutral from Buy at Citi with analyst William Katz saying he views the stock's valuation relative to peers as less attractive at current levels. 4. Monster Beverage (MNST) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Judy Hong saying she expects shares to be range-bound near-term due to soft core Monster sales trends in the US. 5. PNC Financial (PNC) downgraded to Hold from Buy at Rafferty Capital with analyst Richard Bove saying bank stock valuations are too high and growth is lacking. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/18/17
FBCO
04/18/17
INITIATION
Target $174
FBCO
Outperform
Incyte assumed with an Outperform at Credit Suisse
Target $174.
04/19/17
FBCO
04/19/17
NO CHANGE
Target $167
FBCO
Outperform
Incyte price target lowered to $167 from $174 at Credit Suisse
Credit Suisse analyst Alethia Young lowered her price target for Incyte to $167 from $174 on Baricitinib's surprise CRL. The analyst moved baricitinib's U.S. launch to 2019 and lowered the probability of success on U.S. revenues to 80%. Young reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

HUBS

HubSpot

$64.90

-0.9 (-1.37%)

09:09
04/27/17
04/27
09:09
04/27/17
09:09
Recommendations
HubSpot analyst commentary  »

HubSpot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

CLWT

Euro Tech Holdings

09:07
04/27/17
04/27
09:07
04/27/17
09:07
Technical Analysis
Euro Tech Holdings surges after results »

The shares are up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORLY

O'Reilly Automotive

$265.07

1.11 (0.42%)

09:07
04/27/17
04/27
09:07
04/27/17
09:07
Recommendations
O'Reilly Automotive analyst commentary  »

O'Reilly Automotive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 07

    Jun

CFFN

Capital Federal

$14.87

0.03 (0.20%)

09:07
04/27/17
04/27
09:07
04/27/17
09:07
Earnings
Capital Federal reports Q1 EPS 16c, consensus 16c »

Reports Q1 net loan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

VTGN

VistaGen Therapeutics

$1.96

-0.01 (-0.51%)

09:07
04/27/17
04/27
09:07
04/27/17
09:07
Hot Stocks
VistaGen announces publication of AV-101 data in Journal of Pain »

VistaGen Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$44.41

-0.3 (-0.67%)

09:06
04/27/17
04/27
09:06
04/27/17
09:06
Recommendations
PayPal analyst commentary  »

PayPal margins have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

  • 22

    Jun

NOVN

Novan

$5.45

0.06 (1.11%)

09:06
04/27/17
04/27
09:06
04/27/17
09:06
Hot Stocks
Novan presents preclinical data from inflammatory skin diseases program »

Novan announced that data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAZZ

Jazz Pharmaceuticals

$157.75

2.85 (1.84%)

09:06
04/27/17
04/27
09:06
04/27/17
09:06
Recommendations
Jazz Pharmaceuticals analyst commentary  »

Jazz Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

HTM

U.S. Geothermal

$4.17

0.04 (0.97%)

09:05
04/27/17
04/27
09:05
04/27/17
09:05
Hot Stocks
U.S. Geothermal provides update on Raft River expansion program »

U.S. Geothermal provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STX

Seagate

$42.01

-8.5 (-16.83%)

09:05
04/27/17
04/27
09:05
04/27/17
09:05
Recommendations
Seagate analyst commentary  »

Seagate selloff following…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jun

09:05
04/27/17
04/27
09:05
04/27/17
09:05
General news
U.S. durable goods orders rose 0.7% in March »

U.S. durable goods orders…

ORI

Old Republic

$20.22

0.15 (0.75%)

09:04
04/27/17
04/27
09:04
04/27/17
09:04
Earnings
Old Republic reports Q1 EPS 39c, consensus 31c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$11.60

0.12 (1.05%)

09:04
04/27/17
04/27
09:04
04/27/17
09:04
Hot Stocks
Ford says 'fit' for any future downturn in North America »

Comments taken from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

UPS

UPS

$107.62

0.26 (0.24%)

09:04
04/27/17
04/27
09:04
04/27/17
09:04
Hot Stocks
Breaking Hot Stocks news story on UPS »

UPS says Q1 pricing in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 04

    May

  • 16

    May

  • 17

    May

  • 18

    May

  • 19

    May

  • 31

    May

ANTM

Anthem

$179.03

6.57 (3.81%)

, CVS

CVS Health

$82.00

-0.17 (-0.21%)

09:03
04/27/17
04/27
09:03
04/27/17
09:03
Recommendations
Anthem, CVS Health, Express Scripts analyst commentary  »

Anthem price target…

ANTM

Anthem

$179.03

6.57 (3.81%)

CVS

CVS Health

$82.00

-0.17 (-0.21%)

ESRX

Express Scripts

$61.28

1.27 (2.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 10

    May

  • 18

    May

  • 06

    Jun

CBS

CBS

$66.91

0.5 (0.75%)

09:03
04/27/17
04/27
09:03
04/27/17
09:03
Recommendations
CBS analyst commentary  »

CBS valuation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 04

    May

  • 08

    May

  • 15

    Jun

GRUB

GrubHub

$35.02

0.24 (0.69%)

09:03
04/27/17
04/27
09:03
04/27/17
09:03
Earnings
GrubHub sees FY17 revenue $632M-$662M, consensus $644.39M »

Sees FY17 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 11

    May

  • 24

    May

  • 25

    May

BANC

Banc of California

$22.45

-0.15 (-0.66%)

09:03
04/27/17
04/27
09:03
04/27/17
09:03
Hot Stocks
Banc of California names Doug Bowers as CEO, effective May 8 »

Banc of California…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ORRF

Orrstown Financial

$21.95

-0.45 (-2.01%)

09:03
04/27/17
04/27
09:03
04/27/17
09:03
Earnings
Orrstown Financial reports Q1 EPS 24c, consensus 20c »

Net interest income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

GRUB

GrubHub

$35.02

0.24 (0.69%)

09:02
04/27/17
04/27
09:02
04/27/17
09:02
Earnings
GrubHub sees Q2 revenue $153M-$161M, consensus $157.95M »

Sees Q2 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 11

    May

  • 24

    May

  • 25

    May

GRUB

GrubHub

$35.02

0.24 (0.69%)

09:01
04/27/17
04/27
09:01
04/27/17
09:01
Earnings
GrubHub reports Q1 non-GAAP EPS 29c, consensus 24c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 11

    May

  • 24

    May

  • 25

    May

DISCA

Discovery

$29.39

0.1 (0.34%)

09:00
04/27/17
04/27
09:00
04/27/17
09:00
Periodicals
Discovery Asia partners with VS Media, Tabilabo, Variety says »

Discovery Networks Asia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 08

    May

  • 18

    May

  • 31

    May

CNMD

CONMED

$48.13

0.93 (1.97%)

09:00
04/27/17
04/27
09:00
04/27/17
09:00
Recommendations
CONMED analyst commentary  »

CONMED price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 24

    May

UA

Under Armour

$18.14

0.17 (0.95%)

, UAA

Under Armour

$19.71

0.18 (0.92%)

09:00
04/27/17
04/27
09:00
04/27/17
09:00
Hot Stocks
Under Armour CFO sees Q4 to be strongest comparison of 2017 'by far' »

Under Armour CFO David…

UA

Under Armour

$18.14

0.17 (0.95%)

UAA

Under Armour

$19.71

0.18 (0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 31

    May

09:00
04/27/17
04/27
09:00
04/27/17
09:00
General news
U.S. Advance trade deficit in goods widened slightly to -$64.8 B »

U.S. Advance trade…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.